Lifelong Biological Private Limited
About Lifelong Biological Private Limited
Data last updated:
Lifelong Biological Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Trigenesis Lifesciences Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 August 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24239KA2007PTC043662.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Bhawarlal and Sonu Dantewadia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹82,791, a growth of 24% compared to the previous year. For the same year it recorded a net loss of ₹20.73 Lakh and EBITDA of -₹20.53 Lakh. Revenue has grown at a compounded annual rate (CAGR) of 15% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lifelong Biological Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo. 6 Khata No. 178 268/1 268/2, Near Canara Bank Begur Road, Bangalore, Karnataka, India – 560068
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lifelong Biological Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Lifelong Biological Private Limited
FY 2025 filings availableLifelong Biological Private Limited reported revenue of ₹82,791 (up 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over three years, including 24% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹20.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹20.73 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lifelong Biological Private Limited, buy the company report.
Board of directors of Lifelong Biological Private Limited
Lifelong Biological has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhawarlal | Director | 29 Dec 2022 | 3 Years 10 Months | Current |
| Sonu Dantewadia | Director | 30 Aug 2017 | 9 Years 1 Months | Current |
Shareholding
The shareholding of Lifelong Biological Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lifelong Biological Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lifelong Biological Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lifelong Biological Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Lifelong Biological Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Lifelong Biological Private Limited has 7 board changes on record since 2017: 2 appointments and 5 cessations. The latest: Bhawarlal ceased to be Additional Director on 28 Sep 2023.
Frequently asked questions
Lifelong Biological is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 August 2007 (19+ years old) and is registered under CIN U24239KA2007PTC043662.
Lifelong Biological has 2 current directors:
- Bhawarlal - Director
- Sonu Dantewadia - Director
The latest financial statements of Lifelong Biological on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Lifelong Biological is U24239KA2007PTC043662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lifelong Biological was incorporated on 22 August 2007, making it 19+ years old. It is registered with the Registrar of Companies, Bangalore.
Bhawarlal ceased to be Additional Director on 28 Sep 2023. Bhawarlal was appointed as Director on 29 Dec 2022. Vijay Nahar ceased to be Additional Director on 31 Dec 2020. Lifelong Biological has 7 board changes on record in total.
The registered office of Lifelong Biological is at No. 6 Khata No. 178 2681 2682, Near Canara Bank Begur Road, Bangalore, Karnataka, India – 560068.
Lifelong Biological operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Lifelong Biological is compliant as of 31 August 2026. The company is actively filing with the Registrar of Companies.
Lifelong Biological can be reached at its registered office: No. 6 Khata No. 178 2681 2682, Near Canara Bank Begur Road, Bangalore, Karnataka, India – 560068.